Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeramic Fuel Cells Regulatory News (CFU)

  • There is currently no data for CFU

First fully funded BlueGEN programme with iPower

17 Nov 2014 07:00

RNS Number : 1456X
Ceramic Fuel Cells Limited
17 November 2014
 

 

 

17 November 2014

 

First fully funded BlueGEN programme in conjunction with iPower

 

Ceramic Fuel Cells Limited (ASX/AIM: CFU) is pleased to announce the commencement of the first fully funded BlueGEN programme, where the BlueGEN is installed at no cost to the end user. The programme, comprising a 100kW fleet of BlueGENs (a minimum of 65 units) is targeted primarily at public sector organisations that can take advantage of the significant carbon and energy savings BlueGEN has to offer.

The innovative funding structure allows BlueGENs to be installed in end user premises at no upfront cost. End users pay for the costs of gas and BlueGEN maintenance and receive the benefits of the electricity generated and the heat recovered for hot water.

This programme has been developed and will be run by one of CFCL's UK distributors, iPower Energy Limited (iPower).

iPower has also confirmed its interest in developing a second, larger programme with CFCL in the second half of calendar year 2015. These discussions will include various new appraisals and opportunity pipeline assessments which are expected to take place in parallel with the delivery of this first programme.

The terms of the agreement signed with iPower are conditional on drawdown from a facility provided by a 3rd party funder. iPower will make a deposit of £350,000 (A$636,000) which is expected to be received by CFCL early in December. In order to meet the criteria imposed by the 3rd party funding provider, iPower has secured formal confirmations of interest from participating end users for a majority of the installations.

Bob Kennett, CEO of CFCL, commented, "Earlier this year we announced our intention to revise our sales strategy in order to focus primarily on larger scale projects. We are very pleased to see the first of a number of projects of this type come to fruition. It clearly demonstrates the commercial viability of this contractual structure whereby 3rd party funding is used to support the project and provide end users with attractive benefits."

Jon Cape, MD of iPower, commented, "iPower is delighted to be working with CFCL on this ground-breaking initiative. The programme is able to provide customers with net savings of 20-40% on the cost of energy displaced by the BlueGEN with no upfront cost and we see strong potential to progress to a substantially larger Stage 2 Programme for which we are already in dialogue with prospective funding partners."

 

For more information please contact:

 

 

Ceramic Fuel Cells Limited

 

 

 

 

 

 

Clifford Ashby (CFO)

 

Bob Kennett (CEO)

 

 

Tel.

Email

Tel.

Email

 

 

: +61 (0) 3 9554 2300

: investor@cfcl.com.au

: +44 776 4200661

: investor@cfcl.com.au

 

Arden Partners Plc (AIM Nomad)

Steve Douglas Tel. : +44 (0) 12 1423 8900

 

 

About Ceramic Fuel Cells Limited:

 

Ceramic Fuel Cells Limited is a world leader in developing fuel cell technology to generate highly efficient and low-emission electricity from widely available natural gas. More than 500 BlueGEN gas-to-electricity generators have been installed in more than 12 countries around the world and cumulative operating time exceeds 5 million hours. The company is also developing fully integrated power and heating products with leading energy companies E.ON UK in the United Kingdom, GdF Suez in France and EWE in Germany.

The company is listed on the London Stock Exchange AIM market and the Australian Securities Exchange (code CFU).

www.cfcl.com.au

www.bluegen.info

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBBDBXSBBGSL
Date   Source Headline
24th Sep 20077:01 amRNSAnnual Report and Accounts
18th Sep 20079:24 amRNSBoard Appointment
30th Aug 20077:00 amRNSFinal Results
30th Aug 20077:00 amRNSUK Appliance Partner
15th Aug 20074:22 pmRNSAIM Rule 26
2nd Aug 20077:00 amRNSNotice of Results
24th Jul 20077:00 amRNSQ4 Trading Update
24th Jul 20077:00 amRNSProduct Development Agreement
9th Jul 20077:00 amRNSE.ON agreement
25th May 20077:01 amRNSPosting of Newsletter
23rd Apr 20077:00 amRNSQ3 cashflow
23rd Apr 20077:00 amRNSQ3 Trading Statement
17th Apr 20079:24 amRNSPartnership Agreement
12th Apr 200710:18 amRNSNotice of Trading Update
15th Mar 20077:01 amRNSre: agreement
2nd Mar 200710:34 amRNSDirector/PDMR Shareholding
26th Feb 20077:01 amRNSInterim Results
16th Feb 200712:34 pmRNSNotice of Results
31st Jan 20077:02 amRNSQ2 Trading Stmnt & Cashflow
11th Jan 20079:38 amRNSBoard Appointment
15th Dec 20067:58 amRNSProduct Development Agreement
12th Dec 200612:00 pmRNSNew Development Facility
29th Nov 20062:22 pmRNSResult of AGM
30th Oct 20068:03 amRNSGrant of Options
30th Oct 20067:46 amRNSNew Patent Granted
30th Oct 20067:01 amRNSTrading Statement
27th Oct 20069:40 amRNSAnnual Report and Accounts
10th Oct 20068:52 amRNSOpen Briefing
3rd Oct 200612:44 pmRNSHolding(s) in Company
21st Sep 20068:00 amRNSStatutory Accounts
21st Sep 20068:00 amRNSCFCL Announce New Fuel Cell
29th Aug 20067:08 amRNSDirectorate Change
29th Aug 20067:08 amRNSFinal Results
7th Aug 20067:00 amRNSNewsletter / Open Briefing
31st Jul 20067:00 amRNSTrading Statement
21st Jul 20069:15 amRNSHolding(s) in Company
18th Jul 20068:39 amRNSHolding(s) in Company
17th Jul 20067:00 amRNSRegulatory Approval
5th Jul 200611:05 amRNSHolding(s) in Company
29th Jun 200610:00 amRNSContract with EWE
13th Jun 20067:00 amRNSAdditional Listing
6th Jun 20067:01 amRNSAdditional Listing
31st May 20067:00 amRNSAdditional Listing
17th May 20067:00 amRNSAdditional Listing
12th May 20061:43 pmRNSOpen Briefing
11th May 20068:48 amRNSAdditional Listing
9th May 20067:00 amRNSNew patents secured
2nd May 20068:52 amRNSShareholder Newsletter
24th Apr 20067:00 amRNSQuarterly Report
19th Apr 20069:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.